- Email: [email protected]
CME accreditation and certificates
viii
Acknowledgements ESO is grateful to the City of Lugano for their interest and continuous support in the organisation of ECCLU, to the European Society for Medical Oncology for their co-operation and support of travel grants and to the European School of Urology for their collaboration in the programme and assistance in the promotion of the event.
Sharing Progress in Cancer Care ECCLU is part of the Sharing Progress in Cancer Care programme whose sustaining members are: Platinum members: Amgen and Eisai Gold members: Eli Lilly, GlaxoSmithKline Oncology and Merck Serono Silver members: Genomic Health, Novartis Oncology and Sanofi-Aventis
CME accreditation and certificates All participants will be issued a certificate of attendance at the close of the Convention. ECCLU has been appraised and approved by the Accreditation Council of Oncology in Europe (ACOE) acknowledging the quality of the scientific programme and its educational value. ACOE is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS). The “Educational Cancer Convention Lugano − ECCLU: What’s New and What’s True in Genito-urinary Oncology” is designated for a maximum of 15 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA). To convert EACCME credit to AMA PRA category 1 credit, the participant should contact the AMA. The programme is furthermore accredited with 18 ESMO-MORA category 1 points.
Abstracts This book includes abstracts submitted by the invited speakers and those proposed by the participants that were accepted for presentation or publication. Abstracts on basic research, clinical study or a clinical case in genito-urinary oncology, were received within the following categories: − Bladder cancer − Kidney cancer − Prostate cancer − Testicular cancer Abstracts on basic research were considered for poster presentation. Abstracts on clinical cases or clinical studies were considered for oral presentation or poster presentation.
Acknowledgements ESO is grateful to the City of Lugano for their interest and continuous support in the organisation of ECCLU, to the European Society for Medical Oncology for their co-operation and support of travel grants and to the European School of Urology for their collaboration in the programme and assistance in the promotion of the event.
Sharing Progress in Cancer Care ECCLU is part of the Sharing Progress in Cancer Care programme whose sustaining members are: Platinum members: Amgen and Eisai Gold members: Eli Lilly, GlaxoSmithKline Oncology and Merck Serono Silver members: Genomic Health, Novartis Oncology and Sanofi-Aventis
CME accreditation and certificates All participants will be issued a certificate of attendance at the close of the Convention. ECCLU has been appraised and approved by the Accreditation Council of Oncology in Europe (ACOE) acknowledging the quality of the scientific programme and its educational value. ACOE is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS). The “Educational Cancer Convention Lugano − ECCLU: What’s New and What’s True in Genito-urinary Oncology” is designated for a maximum of 15 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA). To convert EACCME credit to AMA PRA category 1 credit, the participant should contact the AMA. The programme is furthermore accredited with 18 ESMO-MORA category 1 points.
Abstracts This book includes abstracts submitted by the invited speakers and those proposed by the participants that were accepted for presentation or publication. Abstracts on basic research, clinical study or a clinical case in genito-urinary oncology, were received within the following categories: − Bladder cancer − Kidney cancer − Prostate cancer − Testicular cancer Abstracts on basic research were considered for poster presentation. Abstracts on clinical cases or clinical studies were considered for oral presentation or poster presentation.